Vivek Ramaswamy’s artful narrative, meticulously tailored for the GOP primary voter, weaves a tale of principled sacrifice and success. According to his version, he helmed the leadership of Roivant, a multi-billion-dollar American pharmaceutical company he founded, and gallantly relinquished his CEO role in 2021 due to his unwavering stance against ESG principles, despite facing opposition from his liberal workforce. While this narrative might seem appealing, it is akin to the endless “flip-flops” that have plagued his campaign—an elaborate work of fiction that unravels upon a modicum of scrutiny.
SEARCH OUR SITE
HOW TO READ
Click on the titles to reveal the full article, the original link, and to reveal the social sharing icons.
RECENT POSTS
- Goodbye to All That – A Lawfare Story
- Not Surprising That Trump Lied – AGAIN
- Trump Job Approval at 38 Percent in New Survey
- Trump Voters Waking Up
- Trump’s 38th Year as a Russian Asset
- ICE Now Snatching Citizens
- Trump Lets the F-Word Fly to Reporter
- Trump Floats $30 Billion Deal to Iran in Secret Nuclear Talks
- Kat Cammack Blames the ‘Left’ for Abortion Ban
- He’s Taking Orders’: Trump’s Ex-‘Trusted Operative’ Says President Has a Boss
- Trump Calls for Deporting US Citizens
- Pardoned Jan. 6 Rioter Who Threatened Police Joins Justice Dept.
- Immigration Raids Leave Crops Unharvested, California Farms at Risk
- US Trade Deficit Surges Despite Donald Trump’s Tariffs
- Israel Snubs Trump Over Demand to ‘Save’ Netanyahu
- ‘It’s a Killing Field’: IDF Soldiers Ordered to Shoot Deliberately at Unarmed Gazans Waiting for Humanitarian Aid
- Rep. Thomas Massie Attacked by Trump PAC
- Exclusive: Details Emerge of Secret Diplomatic Efforts to Restart Iran Talks
- Exclusive: Israel Planned False Flag Operation On US Soil
- New Tip Line Would Pay $1,000 to Report Illegal Immigrants